These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 11939298

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Combinations of ivermectin and diethylcarbamazine for improved control of lymphatic filariasis].
    Moulia-Pelat JP, Nguyen LN, Hascoet H, Nicolas L.
    Parasite; 1996 Mar; 3(1):45-8. PubMed ID: 8731761
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy of a single dose treatment of Wuchereria bancrofti microfilaria carriers with diethylcarbamazine in Matara, Sri Lanka.
    Weerasooriya MV, Kimura E, Dayaratna DA, Weerasooriya TR, Samarawickrema WA.
    Ceylon Med J; 1998 Sep; 43(3):151-5. PubMed ID: 9813933
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF).
    Pani SP, Das LK, Vanamail P.
    J Commun Dis; 2005 Mar; 37(1):12-7. PubMed ID: 16637395
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK, Sanuku N, Baea M, Satofan S, Maki E, Lombore B, Schmidt MS, Siba PM, Weil GJ, Kazura JW, Fleckenstein LL, King CL.
    Clin Infect Dis; 2016 Feb 01; 62(3):334-341. PubMed ID: 26486704
    [Abstract] [Full Text] [Related]

  • 29. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA, Ismail MM, Horton J.
    Parasitol Today; 1999 Sep 01; 15(9):382-6. PubMed ID: 10461168
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
    Bhumiratana A, Koyadun S, Srisuphanunt M, Satitvipawee P, Limpairojn N, Gaewchaiyo G.
    Southeast Asian J Trop Med Public Health; 2005 Mar 01; 36(2):390-407. PubMed ID: 15916046
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R, Sunish IP, Mani TR, Munirathinam A, Arunachalam N, Satyanarayana K, Dash AP.
    Trop Med Int Health; 2006 Jun 01; 11(6):851-61. PubMed ID: 16772007
    [Abstract] [Full Text] [Related]

  • 35. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
    Stolk WA, Swaminathan S, van Oortmarssen GJ, Das PK, Habbema JD.
    J Infect Dis; 2003 Nov 01; 188(9):1371-81. PubMed ID: 14593597
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Lymphatic filariasis in Papua New Guinea: prospects for elimination.
    Bockarie MJ, Kazura JW.
    Med Microbiol Immunol; 2003 Feb 01; 192(1):9-14. PubMed ID: 12592558
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.